Does BIMEKIZUMAB-BKZX Cause Psoriasis? 621 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 621 reports of Psoriasis have been filed in association with BIMEKIZUMAB-BKZX. This represents 11.6% of all adverse event reports for BIMEKIZUMAB-BKZX.
621
Reports of Psoriasis with BIMEKIZUMAB-BKZX
11.6%
of all BIMEKIZUMAB-BKZX reports
0
Deaths
9
Hospitalizations
How Dangerous Is Psoriasis From BIMEKIZUMAB-BKZX?
Of the 621 reports, 9 (1.4%) required hospitalization.
Is Psoriasis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BIMEKIZUMAB-BKZX. However, 621 reports have been filed with the FAERS database.
What Other Side Effects Does BIMEKIZUMAB-BKZX Cause?
Product dose omission issue (694)
Drug ineffective (402)
Product availability issue (364)
Off label use (335)
Psoriatic arthropathy (301)
Injection site pain (263)
Therapy interrupted (252)
Hidradenitis (233)
Inappropriate schedule of product administration (214)
Incorrect dose administered (209)
What Other Drugs Cause Psoriasis?
SECUKINUMAB (21,976)
APREMILAST (19,255)
ADALIMUMAB (16,698)
ETANERCEPT (10,818)
RISANKIZUMAB-RZAA (6,896)
METHOTREXATE (6,283)
USTEKINUMAB (4,955)
INFLIXIMAB (3,524)
CERTOLIZUMAB PEGOL (3,428)
IXEKIZUMAB (2,818)
Which BIMEKIZUMAB-BKZX Alternatives Have Lower Psoriasis Risk?
BIMEKIZUMAB-BKZX vs BINIMETINIB
BIMEKIZUMAB-BKZX vs BIOFLAVONOIDS
BIMEKIZUMAB-BKZX vs BIOTIN
BIMEKIZUMAB-BKZX vs BIPERIDEN
BIMEKIZUMAB-BKZX vs BIRCH TRITERPENES